Clinical Trial Update: ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ONTAK in advanced breast cancer patients who failed prior therapy, spanning Phase 1 and Phase 2, with completed status and results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ONTAK (denileukin diftitox)

Snippet

Sponsor: University of Washington | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-04